drugset / Trial / NCT00400335

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

NCT00400335 ↗

Phase 1 Completed 60 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride

Timeline

Start
2006-10
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Dutasteride Small molecule — —
Subject Testosterone Small molecule — —

Indications